Education
About Us
Working with TipRanks
Follow Us
BeOne Medicines Ltd (HK:6160)
:6160
Total Valuation
BeOne Medicines Ltd has a market cap or net worth of HK$308.47B. The enterprise value is HK$32.35B.
Market CapHK$308.47B
Enterprise ValueHK$32.35B
Share Statistics
BeOne Medicines Ltd has 1,540,976,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,540,976,000
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
BeOne Medicines Ltd’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee486.45K
Profits Per Employee26.12K
Employee Count11,000
Asset Turnover0.65
Inventory Turnover1.30
Valuation Ratios
The current PE Ratio of BeOne Medicines Ltd is 127.3. BeOne Medicines Ltd’s PEG ratio is -0.80.
PE Ratio127.3
PS Ratio6.10
PB Ratio7.49
Price to Fair Value7.49
Price to FCF34.63
Price to Operating Cash Flow43.55
PEG Ratio-0.80
Income Statement
In the last 12 months, BeOne Medicines Ltd had revenue of 5.35B and earned 287.36M in profits. Earnings per share was 0.20.
Revenue5.35B
Gross Profit4.56B
Operating Income447.80M
Pretax Income417.47M
Net Income287.36M
EBITDA589.69M
Earnings Per Share (EPS)0.20
Cash Flow
In the last 12 months, operating cash flow was 1.13B and capital expenditures -266.91M, giving a free cash flow of 865.55M billion.
Operating Cash Flow1.13B
Free Cash Flow865.55M
Free Cash Flow per Share0.56
Dividends & Yields
BeOne Medicines Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.02
52-Week Price Change20.49%
50-Day Moving Average199.37
200-Day Moving Average184.89
Relative Strength Index (RSI)38.10
Average Volume (3m)5.08M
Important Dates
BeOne Medicines Ltd upcoming earnings date is Apr 30, 2026, TBA (Confirmed).
Last Earnings DateFeb 26, 2026
Next Earnings DateApr 30, 2026
Ex-Dividend Date―
Financial Position
BeOne Medicines Ltd as a current ratio of 3.41, with Debt / Equity ratio of 24.70%
Current Ratio3.41
Quick Ratio3.08
Debt to Market Cap0.06
Net Debt to EBITDA―
Interest Coverage Ratio7.68
Taxes
In the past 12 months, BeOne Medicines Ltd has paid 130.11M in taxes.
Income Tax130.11M
Effective Tax Rate0.31
Enterprise Valuation
BeOne Medicines Ltd EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
BeOne Medicines Ltd has HK$4.59B in cash and marketable securities with HK$2.05B in debt, giving a net cash position of HK$2.54B billion.
Cash & Marketable SecuritiesHK$4.59B
Total DebtHK$2.05B
Net CashHK$2.54B
Net Cash Per ShareHK$1.65
Tangible Book Value Per ShareHK$3.05
Margins
Gross margin is 86.19%, with operating margin of 8.37%, and net profit margin of 5.37%.
Gross Margin86.19%
Operating Margin8.37%
Pretax Margin7.80%
Net Profit Margin5.37%
EBITDA Margin11.02%
EBIT Margin8.37%
Analyst Forecast
The average price target for BeOne Medicines Ltd is HK$246.03, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetHK$246.03
Price Target Upside27.94% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast49.63%
EPS Growth Forecast―